AlpineImmuneSciences

#ALPNews: Alpine Immune Sciences is now part of Vertex Pharmaceuticals. For more information about Vertex, follow us at @VertexPharma or visit vrtx.com.

#ALPNews: Today we announced that we will participate in a fireside chat at the upcoming H.C. Wainwright 2nd Annual Autoimmune and Inflammatory Disease Virtual Conference, March 28, 2024, and host investor meetings. For more, visit: bit.ly/4al3Z1Q

#ALPNews: Yesterday, we released our fourth quarter and full year 2023 financial results and conducted a webcast. $ALPN To learn more, read our press release: bit.ly/49ZiTuH or listen to our webcast at: bit.ly/43nvANy

On this @worldkidneyday, Alpine is proud to support a global initiative to raise awareness of the importance of “Kidney Health for All”. At Alpine we are advancing therapies that can potentially improve the lives of patients with autoimmune kidney disease. #healthykidneysforall

#ALPNews: We will release our fourth quarter and full year 2023 financial results on Monday, March 18, and conduct a webcast the same day at 4:30 p.m. ET / 1:30 p.m. PT $ALPN For more:  bit.ly/4c8cUoZ

March is Autoimmune Awareness Month. At Alpine, we are working to advance therapies to create hope and to potentially improve the lives of millions of people living with autoimmune disease. To learn more: bit.ly/3Il4oFf #AutoimmuneAwarenessMonth

This #RareDiseaseDay, we want to take a moment to raise awareness of the 300 million people worldwide living with a rare disease. We're committed to developing treatments for people living with autoimmune and inflammatory diseases so that they may live longer, fuller lives.

#ALPNews: Today we announced that we’ll participate in the upcoming Guggenheim Healthcare Talks 6th Annual Biotechnology Conference and the Oppenheimer & Co 34th Annual Healthcare Life Sciences Conference in February. For more information, visit: bit.ly/48SNWI6

On this #MLKDay, we honor the life and legacy of Dr. Martin Luther King Jr., the civil rights leader who dedicated his life to fighting for racial equality.

Listen to our CEO, Dr. Mitchell Gold present at the 42nd Annual J.P. Morgan Healthcare Conference (@jpmorgan) tomorrow, January 10th, at 7:30 am PT. For more information, visit: bit.ly/486cixQ

#ALPNews: today, Alpine announced that they will present at the 42nd Annual @jpmorgan Healthcare Conference on January 10th, at 7:30 am PT. To access the webcast of Alpine’s presentation, visit bit.ly/486cixQ #JPM2024 #JPM24 $ALPN

We’re looking forward to attending the 65th Annual American Society of Hematology Meeting and Exposition in San Diego, December 9-12. If you’ll be at the meeting, please stop by our booth #3443 to learn more about Alpine and meet our colleagues. We hope to see you there!

Wishing our team of Alpinists, our collaborators and partners, and our entire community a safe and happy Thanksgiving!

#ALPNews: We’re looking forward to participating in a fireside chat as well as investor meetings at the Evercore ISI HealthconX Conference in Miami next week.

#ALPNews: Yesterday we released our third quarter financial results.   To learn more, read our press release: bit.ly/3R1i51B $ALPN

We recently presented encouraging initial clinical data for povetacicept at ASN Kidney Week 2023. Watch Prof. Jonathan Barratt and Dr. Brad Rovin discuss their perspectives. #IgAN #pMN

On this day, we recognize the brave individuals who serve our country. We thank you and your families for your courage, sacrifice, and strength.

We're thrilled to be listed on @DeloitteUS’s Technology Fast 500 this year! The award recognizes the most innovative, fastest-growing technology companies in the country. Learn more: bit.ly/47m6D5Y.

It was an exciting ASN Kidney this year! We were honored to join industry experts and share the first clinical data on povetacicept in glomerulonephritis, including #IgAN, and enhance our understanding of the latest advancements in nephrology. #KidneyWk

Today at the American Association of Neuromuscular & Electrodiagnostic Medicine (#AANEM) Annual Meeting, Marcia Friedman, MD, Associate Medical Director at Alpine, will new present preclinical data on povetacicept in myasthenia gravis. Learn more: bit.ly/3MrvlK2